-
Cytocom Acquires ImQuest Life Sciences
contractpharma
July 21, 2020
Gains ImQuest Pharmaceuticals, BioSciences, and Life Sciences divisions, adding drug development and CRO ops, and pipeline assets.
-
Amgen makes $421m additional investment in BeiGene
pharmaceutical-technology
July 15, 2020
Amgen has made an additional investment of approximately $421m to the registered direct offering of ordinary shares of Chinese biotechnology firm BeiGene.
-
ABITEC Acquires Larodan AB Research Grade Lipids
americanpharmaceuticalreview
July 10, 2020
ABITEC Corporation has acquired Larodan AB, a manufacturer and international marketer of high-purity research grade lipids. This strategic acquisition will expand ABITEC’s functional lipid product offerings and scientific capabilities.
-
LGC Acquires The Native Antigen Company
contractpharma
July 10, 2020
NAC was one of the first companies globally to offer antigens for SARS-COV-2 and continues to support the global response to the COVID-19 pandemic.
-
Healthcare industry reports deals worth US $8.2-bn in June’20: GlobalData
expresspharma
July 09, 2020
In June 2020, the healthcare industry reported 87 deals worth US $8.2 billion as compared to last 12 months’ average (June 2019 to May 2020) of 64 deals worth US$17.7 billion.
-
Frontage Acquires ACME Bioscience
contractpharma
July 09, 2020
Expands synthetic and medicinal chemistry and process research and development services.
-
Croda Announces Acquisition of Avanti Polar Lipids
americanpharmaceuticalreview
July 08, 2020
Croda International has agreed to acquire Avanti Polar Lipids, a company providing lipid-based drug delivery technologies for next generation pharmaceuticals.
-
KKR to acquire controlling stake in JB Chemicals and Pharmaceuticals
expresspharma
July 06, 2020
KKR will make the investment through its subsidiaries, Tau Investments Holdings, Tau Holdco, and KKR Asia III Fund Investments.
-
GMM Pfaudler acquires De Dietrich Process Systems’ Glass Lined Equipment manufacturing’s Hyderabad facility
expresspharma
July 02, 2020
A consideration of Euro 6.25 million will be paid for the proposed transaction subject to completion of the final due diligence and other documentation.
-
Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m
pharmaceutical-business-review
July 01, 2020
US private equity firm Carlyle Group has agreed to acquire a stake of 20% stake in Piramal Pharma, the pharmaceutical business of Indian conglomerate Piramal Enterprises, in a deal worth up to $490m.